The short version
Zepbound is harder to source through telehealth than Wegovy because Eli Lilly's distribution agreements with telehealth platforms are narrower than Novo Nordisk's. The programs that prescribe Zepbound either run prior auth on commercial insurance, route patients through LillyDirect's cash-pay channel or both. Programs that prescribe compounded tirzepatide instead of brand Zepbound are excluded here, that's a separate category with separate regulatory exposure.
What we considered
- Will actively prescribe brand Zepbound (not just compounded tirzepatide)
- Runs prior authorization if you have commercial insurance
- Speed from intake to first Zepbound prescription
- Total cash-pay cost when insurance falls through
Top pick: PlushCare

PlushCare uses your real commercial insurance and actively runs prior auth on Zepbound. If your plan covers it, you land on a $25-$50 monthly copay. If it doesn't, the cash-pay path is straightforward.
Read the full PlushCare review →
Other strong picks


